These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24850617)

  • 21. Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells.
    Kong L; Zhao Q; Wang X; Zhu J; Hao D; Yang C
    BMC Complement Altern Med; 2014 Dec; 14():481. PubMed ID: 25496242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture.
    Takahashi E; Mukohyama H; Aoki K; Duarte WR; Lerner UH; Ohya K; Omura K; Kasugai S
    J Med Dent Sci; 2002 Dec; 49(4):109-20. PubMed ID: 12641381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
    Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts.
    Ahn SJ; Baek JM; Cheon YH; Park SH; Lee MS; Oh J; Kim JY
    Am J Chin Med; 2015; 43(4):715-29. PubMed ID: 26119955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safflower seed extract inhibits osteoclast differentiation by suppression of the p38 mitogen-activated protein kinase and IκB kinase activity.
    Moon HJ; Kim EK; Nam YS; Kim JH; Ko WK; Lee JM; Lee CH; Jang JB; Lee KS; Kwon IK
    Phytother Res; 2012 Nov; 26(11):1648-55. PubMed ID: 22389167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.
    Yang YM; Kim MS; Son A; Hong JH; Kim KH; Seo JT; Lee SI; Shin DM
    J Bone Miner Res; 2009 Oct; 24(10):1763-9. PubMed ID: 19419309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells.
    Nikhil K; Sharan S; Roy P
    Pharmacol Rep; 2015 Dec; 67(6):1264-72. PubMed ID: 26481551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
    Zhao D; Shi Z; Warriner AH; Qiao P; Hong H; Wang Y; Feng X
    PLoS One; 2014; 9(7):e102706. PubMed ID: 25032991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice.
    Baek JM; Kim JY; Cheon YH; Park SH; Ahn SJ; Yoon KH; Oh J; Lee MS
    Molecules; 2014 Aug; 19(8):11628-44. PubMed ID: 25100255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
    Shim KS; Ha H; Kim T; Lee CJ; Ma JY
    Am J Chin Med; 2015; 43(5):1013-30. PubMed ID: 26205967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
    Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
    Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1.
    Kim JY; Kim JY; Cheon YH; Kwak SC; Baek JM; Kim YC; Yoon KH; Oh J; Lee MS
    Int Immunopharmacol; 2014 May; 20(1):213-20. PubMed ID: 24630975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.
    Ha H; Shim KS; Kim T; Lee CJ; Park JH; Kim HS; Ma JY
    BMC Complement Altern Med; 2014 Sep; 14():352. PubMed ID: 25249312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages.
    Hung CJ; Kao CT; Chen YJ; Shie MY; Huang TH
    J Endod; 2013 Dec; 39(12):1557-61. PubMed ID: 24238446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.